Cargando…
Long Non-coding RNA Regulation of Mesenchymal Stem Cell Homeostasis and Differentiation: Advances, Challenges, and Perspectives
Given the self-renewal, multi-differentiation, immunoregulatory, and tissue maintenance properties, mesenchymal stem cells (MSCs) are promising candidates for stem cell-based therapies. Breakthroughs have been made in uncovering MSCs as key contributors to homeostasis and the regenerative repair of...
Autores principales: | Yang, Yanlei, Liu, Suying, He, Chengmei, Chen, Zhilei, Lyu, Taibiao, Zeng, Liuting, Wang, Li, Zhang, Fengchun, Chen, Hua, Zhao, Robert Chunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339964/ https://www.ncbi.nlm.nih.gov/pubmed/34368161 http://dx.doi.org/10.3389/fcell.2021.711005 |
Ejemplares similares
-
Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives
por: Yang, Yanlei, et al.
Publicado: (2022) -
LncRNA LYPLAL1-AS1 rejuvenates human adipose-derived mesenchymal stem cell senescence via transcriptional MIRLET7B inactivation
por: Yang, Yanlei, et al.
Publicado: (2022) -
EZH2 Promotes T Follicular Helper Cell Differentiation Through Enhancing STAT3 Phosphorylation in Patients With Primary Sjögren’s Syndrome
por: He, Chengmei, et al.
Publicado: (2022) -
Iguratimod suppresses Tfh cell differentiation in primary Sjögren’s syndrome patients through inhibiting Akt/mTOR/STAT3 signaling
por: Lyu, Taibiao, et al.
Publicado: (2023) -
Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges
por: He, Chengmei, et al.
Publicado: (2021)